Table of Contents
ISRN Pharmacology
Volume 2014, Article ID 259476, 8 pages
http://dx.doi.org/10.1155/2014/259476
Research Article

Effect of Educational Intervention on Adverse Drug Reporting by Physicians: A Cross-Sectional Study

1Department of Pharmacology, AIIMS Rishikesh, Virbhadra Road, Rishikesh, Uttarakhand 249 201, India
2Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, Uttarakhand 248140, India

Received 30 January 2014; Accepted 20 February 2014; Published 18 March 2014

Academic Editors: G. Gervasini and T. B. Vree

Copyright © 2014 Manisha Bisht et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Wu and N. Pantaleo, “Evaluation of outpatient adverse drug reactions leading to hospitalization,” American Journal of Health-System Pharmacy, vol. 60, no. 3, pp. 253–259, 2003. View at Google Scholar · View at Scopus
  2. M. Pirmohamed, S. James, S. Meakin et al., “Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients,” British Medical Journal, vol. 329, no. 7456, pp. 15–19, 2004. View at Google Scholar · View at Scopus
  3. R. Rodríguez-Monguió, M. J. Otero, and J. Rovira, “Assessing the economic impact of adverse drug effects,” PharmacoEconomics, vol. 21, no. 9, pp. 623–650, 2003. View at Google Scholar · View at Scopus
  4. K. Nelson and R. Talbert, “Drug-related hospital admissions,” Pharmacotherapy, vol. 16, no. 4, pp. 701–707, 1996. View at Google Scholar · View at Scopus
  5. D. Wysowski and L. Swartz, “Adverse drug event surveillance and drug withdrawals in the United States, 1969–2002: the importance of reporting suspected reactions,” Archives of Internal Medicine, vol. 165, no. 12, pp. 1363–1369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Lopez-Gonzalez, M. T. Herdeiro, and A. Figueiras, “Determinants of under-reporting of adverse drug reactions: a systematic review,” Drug Safety, vol. 32, no. 1, pp. 19–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Smith, P. Bennett, H. Pearce et al., “Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines,” British Journal of Clinical Pharmacology, vol. 42, no. 4, pp. 423–429, 1996. View at Google Scholar · View at Scopus
  8. S. Prakash, “Pharmacovigilance in India,” Indian Journal of Pharmacology, vol. 39, no. 3, p. 123, 2007. View at Google Scholar · View at Scopus
  9. K. A. Oshikoya and J. O. Awobusuyi, “Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria,” BMC Clinical Pharmacology, vol. 9, p. 14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Rehan, K. Vasudev, and C. D. Tripathi, “Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers,” The National Medical Journal of India, vol. 15, no. 1, pp. 24–26, 2002. View at Google Scholar · View at Scopus
  11. J. O. Fadare, O. O. Enwere, A. O. Afolabi, B. A. Z. Chedi, and A. Musa, “Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria,” Tropical Journal of Pharmaceutical Research, vol. 10, no. 3, pp. 235–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Radhakrishnan, V. Sudha, and M. V. Danturulu, “An educational intervention to assess knowledge attitude practice of pharmacovigilance among Health care professionals in an Indian tertiary care teaching hospital,” International Journal of PharmTech Research, vol. 3, no. 2, pp. 678–692, 2011. View at Google Scholar
  13. R. D. Kulkarni, “Reporting systems for rare side effects of non-narcotic analgesics in India. Problems and opportunities,” Medical Toxicology and Adverse Drug Experience, vol. 1, no. 1, pp. 110–113, 1986. View at Google Scholar · View at Scopus
  14. Y. K. Gupta, “Ensuring patient safety-launching the new pharmacovigilance programme of India,” Pharma Times, vol. 42, no. 8, pp. 21–26, 2010. View at Google Scholar · View at Scopus
  15. S. Khan, C. Goyal, N. Chandel, and M. Rafi, “Knowledge, attitudes and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: an observational study,” Journal of Natural Science, Biology and Medicine, vol. 4, no. 1, pp. 191–196, 2013. View at Publisher · View at Google Scholar
  16. C. Desai, G. Iyer, J. Panchal, S. Shah, and R. Dikshit, “An evaluation of knowledge, attitude and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital,” Perspectives in Clinical Research, vol. 2, no. 4, pp. 129–136, 2011. View at Publisher · View at Google Scholar
  17. Q. Li, S. Zhang, H. Chen et al., “Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions,” Chinese Medical Journal, vol. 117, no. 6, pp. 856–861, 2004. View at Google Scholar · View at Scopus
  18. K. Santosh, T. Pramote, G. Sarun, and E. Ralph, “Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal,” BMC Pharmacology and Toxicology, vol. 14, p. 16, 2013. View at Publisher · View at Google Scholar
  19. S. Chatterjee, N. Lyle, and S. Ghosh, “A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India,” Drug Safety, vol. 29, no. 7, pp. 641–642, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Ekman and M. Bäckström, “Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden,” European Journal of Clinical Pharmacology, vol. 65, no. 1, pp. 43–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. J. Belton, S. C. Lewis, S. Payne, M. D. Rawlins, and S. M. Wood, “Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom,” British Journal of Clinical Pharmacology, vol. 39, no. 3, pp. 223–226, 1995. View at Google Scholar · View at Scopus
  22. K. Belton, “Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group,” European Journal of Clinical Pharmacology, vol. 52, no. 6, pp. 423–427, 1997. View at Publisher · View at Google Scholar
  23. E. Ekman and M. Bäckström, “Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden,” European Journal of Clinical Pharmacology, vol. 65, no. 1, pp. 43–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. I. A. Eland, K. J. Belton, A. C. Van Grootheest, A. P. Meiners, M. D. Rawlins, and B. H. C. Stricker, “Attitudinal survey of voluntary reporting of adverse drug reactions,” British Journal of Clinical Pharmacology, vol. 48, no. 4, pp. 623–627, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Tabali, E. Jeschke, A. Bockelbrink et al., “Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine,” BMC Public Health, vol. 9, p. 274, 2009. View at Publisher · View at Google Scholar · View at Scopus